Cross-area translational
Connect microbial, immune, and host-response results to infection episodes and outcomes through shared subject and episode identity, without duplicating another area's pipeline.
Research question
How do versioned results from Microbiology, Computational Biology, and Immunology connect to infection timing, interventions, and clinical outcomes in one cohort?
Who this is for
- Translational infection and vaccine research teams
- Multi-site programs harmonizing pathogen, host, and clinical data
- Groups building an infection-episode layer over other areas' science
Data requirements
| Data | Required | Purpose |
|---|---|---|
| Infectious-disease study with episodes and outcomes | Yes | The episode and outcome model |
| Shared subject/episode/specimen identifiers | Yes | The integration contract across areas |
| Versioned results in other areas | Yes | Pathogen, host, or immune features to link |
Workflow
Model episodes and outcomes → Link versioned results from other areas by subject/episode
→ Compare host, immune, and pathogen features against outcomes
→ Grounded interpretation across linked runs
Ownership follows the scientific method, not the disease label: Microbiology owns pathogen measurement, Computational Biology owns host transcriptomics, and Immunology owns immune computation. Infectious Disease owns the human and population event model and consumes their immutable, versioned artifacts.
Expected outputs
- Episode-linked evidence views spanning multiple areas, with provenance preserved
- Outcome comparisons across pathogen, host, or immune-defined groups
- Grounded interpretation that cites computed metrics and flags confounding, never asserting transmission or causation